This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Veterinary Pharmaceutical Solutions acquired Heska Corporation from Mars, Incorporated. CI
Heska Corporation(NasdaqCM:HSKA) dropped from S&P 600 CI
Heska Corporation(NasdaqCM:HSKA) dropped from S&P Composite 1500 CI
Heska Corporation(NasdaqCM:HSKA) dropped from S&P Healthcare Equipment Select Industry Index CI
Heska Corporation(NasdaqCM:HSKA) dropped from S&P TMI Index CI
Heska Corporation(NasdaqCM:HSKA) dropped from S&P 1000 CI
Heska Corporation(NasdaqCM:HSKA) dropped from S&P Global BMI Index CI
Heska Corporation(NasdaqCM:HSKA) dropped from S&P 600 Health Care CI
Heska Corporation Announces Board Changes CI
Heska Corporation(NasdaqCM:HSKA) dropped from NASDAQ Composite Index CI
Antech Diagnostics, Inc. completed the acquisition of Heska Corporation from BlackRock, Inc., The Vanguard Group, Inc. and others. CI
EXp World to Replace Heska, Privia Health to Replace Ruth's Hospitality on S&P SmallCap 600; Shares Rise MT
EXp World to Replace Heska, Privia Health to Replace Ruth's Hospitality on S&P SmallCap 600 MT
Transcript : Heska Corporation - Shareholder/Analyst Call
Earnings Flash (HSKA) HESKA CORPORATION Posts Q1 Revenue $62.4M MT
Earnings Flash (HSKA) HESKA CORPORATION Reports Q1 EPS $0.17 MT
Heska Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Heska Corporation - Shareholder/Analyst Call
Heska Agrees to Buyout Deal With Dog Food Pedigree Maker Mars MT
Alliance Global Downgrades Heska to Neutral From Buy, Cuts Price Target to $120 From $129 MT
Morgan Stanley Upgrades Heska to Equalweight From Underweight, Raises Price Target to $120 From $58 MT
Heska Agrees to be Acquired by Mars; Shares Rise MT
Mars to buy veterinary diagnostics firm Heska for $1.3 bln RE
Sector Update: Healthcare Stocks Lose Ground in Late Trading MT
Sector Update: Health Care MT
Chart Heska Corporation
More charts
Heska Corporation sells, manufactures, markets and supports diagnostic and specialty products and solutions for veterinary practitioners. The Company's portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The Company has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.
More about the company
  1. Stock Market
  2. Equities
  3. HSKA Stock
  4. News Heska Corporation
  5. Heska : Raymond James Adjusts Price Target on Heska to $225 From $145, Maintains Outperform Rating